Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4405 results

Sort By:

Exercise in Triple- Negative Breast Cancer

Study ID: NCT06672120
Start Date: 2025-12-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Exercise training

Sponsor

Technical University of Munich

Source: clinicaltrials.gov

Share:
Add to list

Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise

Study ID: NCT05025774
Start Date: 2025-01-01
End Date: 2025-08-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

90

Intervention / Treatment

Physical activity

Sponsor

Masonic Cancer Center, University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

Pilot Randomized Clinical Trial of Change My Story

Study ID: NCT06389565
Start Date: 2025-01-01
End Date: 2026-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Problem Solving Therapy

Change My Story

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Tumors

Study ID: NCT06202066
Start Date: 2024-12-15
End Date: 2028-10-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

132

Intervention / Treatment

Biospecimen Collection

Computed Tomography

Incomplete Freund''s Adjuvant

Magnetic Resonance Imaging

Sargramostim

SVN53-67/M57-KLH Peptide Vaccine

Temozolomide

Sponsor

Roswell Park Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Pharmacokinetics，Safety and Efficacy of ZSP1273 in Children 2-17 Years Old With Influenza A

Study ID: NCT06656026
Start Date: 2024-11-30
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

72

Intervention / Treatment

ZSP1273 granules

Sponsor

Guangdong Raynovent Biotech Co., Ltd

Source: clinicaltrials.gov

Share:
Add to list

Milk for Diabetes Prevention

Study ID: NCT06513026
Start Date: 2025-01
End Date: 2027-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Lactose-Containing Milk

Lactose-Free Milk

Sponsor

Albert Einstein College of Medicine

Source: clinicaltrials.gov

Share:
Add to list

Safety and Efficacy of Conestat Alfa for ACE-Induced Angioedema

Study ID: NCT06679426
Start Date: 2024-12-01
End Date: 2025-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

24

Intervention / Treatment

Conestat Alfa

Sponsor

University of Cincinnati

Source: clinicaltrials.gov

Share:
Add to list

A Study of CHS-1000 in Participants With Advanced or Metastatic Solid Tumors

Study ID: NCT06389526
Start Date: 2025-02-15
End Date: 2028-05-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

48

Intervention / Treatment

CHS-1000

triplimab

Sponsor

Coherus Biosciences, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Platelet Rich Plasma for Uterine Scar

Study ID: NCT05224726
Start Date: 2025-01
End Date: 2026-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Platelet Rich Plasma

Sponsor

The University of Texas Health Science Center, Houston

Source: clinicaltrials.gov

Share:
Add to list

Huntington's Disease and Pain

Study ID: NCT06693466
Start Date: 2025-01
End Date: 2026-07
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Facial expression block

Conditioned pain modulation block

Pain facilitation block

Sponsor

Leiden University Medical Center

Source: clinicaltrials.gov

Share:
Add to list